Ledger.Open graph →
SEC Form D · filed August 10, 2023

Dracen Pharmaceuticals, Inc

Offering
$2.8M
Sold
$2.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Jonathan M. Leff · New York, NYDirectorAsher M. Rubin · Baltimore, MDExecDrew M. Pardoll, M.D., Ph.D · Baltimore, MDDirectorDennis M. Bilski · New York, NYExecAsher M. Rubin · Baltimore, MDExecDrew M. Pardoll, M.D., Ph.D · Baltimore, MDDirectorDennis M. Bilski · New York, NYExecJonathan M. Leff · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗